Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Urogynecology (Phila) ; 30(3): 309-313, 2024 03 01.
Artigo em Inglês | MEDLINE | ID: mdl-38484247

RESUMO

ABSTRACT: Concurrent cervical cancer with advanced pelvic organ prolapse is rare: there are no well-established treatment recommendations. It is hypothesized that chronic irritation, as with long-standing pelvic organ prolapse, may lead to dysplasia and human papillomavirus-independent carcinoma, which represents only 5% of cervical cancers. Two patients with complete uterine procidentia were referred to gynecologic oncology with cervical squamous cell carcinoma; both were clinically staged as International Federation of Gynaecology and Obstetrics IB3. Treatment planning was complicated by procidentia in both cases. Standard definitive treatment of locally advanced cervical cancer is radiation therapy and concurrent chemotherapy; however, the mobility and externalization of the target lesion raised concerns regarding anatomic reproducibility during radiation treatment. After multidisciplinary team discussion (gynecologic oncology, urogynecology, radiation oncology), surgical resection and co-management with gynecologic oncology and urogynecology were successfully performed for definitive management for both patients. Although rare, this case study demonstrates the importance of multidisciplinary coordination in these complex clinical scenarios.


Assuntos
Carcinoma de Células Escamosas , Neoplasias dos Genitais Femininos , Prolapso de Órgão Pélvico , Neoplasias do Colo do Útero , Humanos , Feminino , Neoplasias do Colo do Útero/complicações , Cisplatino , Carcinoma de Células Escamosas/complicações , Neoplasias dos Genitais Femininos/tratamento farmacológico , Reprodutibilidade dos Testes , Prolapso de Órgão Pélvico/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...